Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : WAND (Milestone Scientific) -- Ignore unavailable to you. Want to Upgrade?

To: Zeev Hed who wrote (581)	6/8/1998 2:16:00 PM
From: Brooks Jackson	Read Replies (1) \| Respond to of 717

Zeev: I hope you mean "appetizing" on the long side. Do I recall correctly that you don't short?

To: Zeev Hed who wrote (581)	6/9/1998 9:50:00 AM
From: Mason Barge	Read Replies (2) \| Respond to of 717

It's hard to read at this point. I think they are actually selling product. The biggest problem I have with this company is the management, which really does seem to be having difficulty with execution in a lot of ways. But they haven't done a terrible job -- they do have the thing up and running. What they might need to do at this point is start showing a profit and attempt to grow incrementally. If this thing becomes self-sustaining for a quarter or two, they can pre-announce an extraordinary marketing push and show a little loss without hurting share price. I'm afraid we are in a more realistic range at this point. I haven't ridden it all the way down, but I've taken two hits, one from buying at 24 and selling at a loss, and then rebuying at 16 recently (I think this last was the worst I've ever done). It's been an object lesson in story stocks for me. At least I got out of Quigley with a profit! Anyway, I think they have the core of a good business and it ought to be pretty good at this point, especially if they start placing it with podiatrists.